Januvia (sitagliptin) impairs the immune system.
Januvia helps treat diabetes by inhibiting the breakdown of incretins...hormones that increase insulin release in response to meals. It does this by blocking dipeptidyl peptidase-4 (DPP-4), an enzyme that inactivates incretins.
Some experts are concerned there may be rare effects associated with other substrates of DPP-4. These may involve immune function including inhibition of T-cell activity.
These concerns are fueled by reports of necrotic skin lesions in monkeys taking another "gliptin" up for approval called Galvus (vildagliptin).
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote